July 2008 libre acèss (free access,) for OTC market was implemented – a measure where some selected OTC products were made available over the counter within…
In Conversation
FPS is a hundred year old organization with roots in the beginning of the last century representing today SME suppliers to the health industries. Given the…
US pharmaceutical companies have long been in the French market but in your experience how do you feel they have integrated the differences in culture? Is…
Generic drugs were a very late arrival for the French market in comparison with other European markets and healthcare systems on a par with the French…
Throughout your prolific career in the pharmaceutical industry, what would you describe have been the major changes in the French pharmaceutical market and to what extent…
France is a major pharmaceutical market, leader in Europe and number three in the world but it seems in biotechnologies, France lags behind. In your opinion,…
After spending 15 years at the CEA (Nuclear Energy Center), you just accepted an offer to become the General Manager of INSERM at the very moment…
July 2008 libre acèss (free access,) for OTC market was implemented – a measure where some selected OTC products were made available over the counter within…
The US chooses to price its innovative drugs based on a market approach which is very different from the French system. Could you explain how the…
The creation of AFSSAPS in 1999 was a milestone for the industry as it became the organism which gives authorization to enter a drug into the…
What was the idea behind the creation of the « Etats Generaux de l’industrie » (General States of Industries)? What can we expect from them? The…
Why was the time right in 2000 to start Paion, and how did your background and experiences in the pharma industry, academia and consulting help you…
